VERA PHARMA LIMITED

Active

VERA PHARMA LIMITED having CIN U24230TG1995PLC020644 is 30 years & 3 days old Public Indian Company incorporated on 08 Jun 1995. It is classified as Non-government company and is registered at ROC Hyderabad. Its authorized share capital is Rs. 85,000,000 and its paid up capital is Rs. 83,588,000. It's NIC code is 24230 (which is part of its CIN).

As per the NIC code, it is involved in . VERA PHARMA LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2022. Directors of VERA PHARMA LIMITED are Chandrashekar Gorrepati Rao and Maganti Bijili kumari.

VERA PHARMA LIMITED ' Corporate Identification Number (CIN) is U24230TG1995PLC020644 and its registration number is 020644. Users may contact VERA PHARMA LIMITED on its Email address - verapharma@gmail.com Registered address of VERA PHARMA LIMITED is 3-6-69, FLAT NO. 409, VENKATARAMA TOWERS, BASHEERBAGH,HYDERABAD,Telangana,India-500029. Current status of VERA PHARMA LIMITED is - Active.

Key Indicators

Authorised Capital

85,000,000

as on 11/06/2025

Paid Up Capital

83,588,000

as on 11/06/2025

Company Age

30 Year, 0 Months

Last Filing with ROC

2 Year, 8 Months

CIN	U24230TG1995PLC020644
Company Status	Active
Registration Number	020644
Date of Incorporation	06/08/1995
RoC	ROC Hyderabad
Company Age	30 years & 11 days
Authorized Capital	₹ 85000000
Paid-up capital	₹ 83588000
Company Category	Company limited by shares
Company Sub-Category	Non-government company
Class of company	Public
Activity
Listing status	Unlisted
Date of Last Annual General Meeting	31-03-2022
Date of Latest Balance Sheet	31-03-2022

Contact

Email ID	verapharma@gmail.com
Address	H.No.8-3-833/79, Ground Floor, Kamalapuri Colony Phase III, Road No.2, Banjara Hills, HYDERABAD Telangana India 500073
Website	********.com
Contact Number	+91*******

Location on Map

Director

Designation	Name	Date OF Appointment	DIN	PAN	Tenure
Director	RANGANATH BABU GORREPATI	09/03/1997	01429449	*****7790A	27 years
Director	MAGANTI BIJILI KUMARI	08/22/2023	00909970	*****9211E	1 years
Director	CHANDRASHEKAR GORREPATI RAO	09/01/2014	06915309	*****9871F	10 years

Companies connected through Directors

Name	Status	Paid Up Capital	Common Directors	Address
RAMPEX LABS PRIVATE LIMITED	Active	26,68,72,930.00	1	Telangana
VANI PLASTICS & PLANTATIONS PRIVATE LIMITED	Active	53,34,000.00	2	Telangana
VANIMAX SOLAR SYSTEMS PRIVATE LIMITED	Active	1,90,00,000.00	2	Telangana
KRISHNA POLY PACKS PVT LTD	Active	1,44,00,000.00	2	Telangana

Charges on assets

BANK OF INDIA

No. of Loans: 1

Total Amount: 3,000,000.00 cr

IDBI BANK

No. of Loans: 1

Total Amount: 2,000,000.00 cr

Charge Holder	Branch	Amount	Date of creation	Modification	Satisfaction	Status
BANK OF INDIA	GROUNG FLOOR, PTI BUILDING, AC GAURDS, MASAB TANK	3,000,000	22 Nov, 2012	-	04 Feb, 2016	Closed
IDBI BANK	CUFFE PARADE, MUMBAI	2,000,000	02 May, 2011	-	03 Oct, 2012	Closed

Registered Details

CIN

U24230TG1995PLC020644

PAN

U24230TG1995PLC020644

Incorporation

10 years , 9 month

Company Email

verapharma@gmail.com

Paid up Capital

₹ 83,588,000

Authorised Capital

₹ 85,000,000

Type

Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

9.29%

₹ 0

EBITDA

29%

₹ 0

Net Profit

29%

₹ 0

Networth

29%

₹ 0

Borrowings

9.29%

₹ 0

Assets

9.29%

₹ 0

Gross Margin

9.29%

₹ 0

Operating Margin

29%

₹ 0

Net Profit Margin

29%

₹ 0

Return on Equity

29%

₹ 135,987.4

ROCE

9.29%

₹ 140,987.4

Debt to Equity

9.29%

₹ 0

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales
Operating profit
Net profit
Gross margin
Operating margin
Net margin
Networth
Borrowings
Assets
Debt to equity
Current ratio
ROE
Days payable
WC days

Balance Sheet

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
I.Revenue from operations
II. Other income
III.Total Revenue (I + II)
IV.Expenses +
(1)Cost of materials consumed
(2)Purchases of Stock-in-Trade
(3)Changes in inventories of finished goods work-in-progress and
(4)Stock-in-Trade
(5)Employee benefits expense
(6)Finance costs
(7)Depreciation and amortisation expense
(8)Other expenses
(9)Total expenses
VProfit before exceptional and extraordinary items and tax (III - IV)
VIExceptional items
VII.Profit before extraordinary items and tax (V - VI)
VIII.Extraordinary items
IX.Profit before tax (VII- VIII)
X. Tax expense: +
(1)Current tax
(2)Deferred tax
XI.Profit (Loss) for the period from continuing operations (VII-VIII)
XII.Profit/(loss) from discontinuing operations
XIII.Tax expense of discontinuing operations
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)
XV.Profit (Loss) for the period (XI + XIV)
XVI.Earnings per equity share: +
(1) Basic
(2)Diluted

Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit +
Operating margin %
Other income
Interest
Depreciation
Exceptional items
Profit before tax
Tax
Profit - disc. ops
Net profit
Net margin %

Ratio

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +	0.00	0.00	0.00	0.00	0.00
Total Debt/Equity	0.00	0.00	0.00	0.00	0.00
Net Debt/Equity	0.00	0.00	0.00	0.00	0.00
Total Debt/Assets	0.00	0.00	0.00	0.00	0.00
Total Assets/Equity	0.00	0.00	0.00	0.00	0.00
Liquidity +	0.00	0.00	0.00	0.00	0.00
Current Ratio	0.00	0.00	0.00	0.00	0.00
Quick Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage	0.00	0.00	0.00	0.00	0.00
Performance	0.00	0.00	0.00	0.00	0.00
Gross Margin	0.00	0.00	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00	0.00	0.00
Net Margin	0.00	0.00	0.00	0.00	0.00
Return +	0.00	0.00	0.00	0.00	0.00
Return on Equity	0.00	0.00	0.00	0.00	0.00
Pre-tax ROCE	0.00	0.00	0.00	0.00	0.00
Return on Assets	0.00	0.00	0.00	0.00	0.00
Pre-tax ROIC	0.00	0.00	0.00	0.00	0.00
Efficiency +	0.00	0.00	0.00	0.00	0.00
Days Payable	0.00	0.00	0.00	0.00	0.00
Days Inventory	0.00	0.00	0.00	0.00	0.00
Days Receivable	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Total Asset Turnover	0.00	0.00	0.00	0.00	0.00
Working Capital	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle	0.00	0.00	0.00	0.00	0.00
Working Capital Days	0.00	0.00	0.00	0.00	0.00

Subsidiaries, Associate Companies & Join Ventures of Vera Pharma Limited

Company Identifier	Name	Percentage of Shares Held

Fund Raising Activity of Vera Pharma Limited

Date of Allotment	Securities Alloted	Terms	Number of Securities	Nominal Amount	Premium Amount Due & Payable	Premium Amount Paid	Total Discount	Amount to be Paid on Calls (Excluding Premium)	Attachments

Board Meetings of Vera Pharma Limited

Date of Filing	Date of Dispatch of Notice	Date of Passing Resolution	Section (Companies Act 2013)	Section (Companies Act 1956)	Subject Matter of Resolution	Resolution Agreed By	Resolution Type	Additional Documents

Auditors of Vera Pharma Limited

Financial Year	Name of Auditor or Firm	PAN of Auditor or Firm	Membership Number / Registration Number	Name of Auditor Signing Report	Membership Number of Auditor Signing Report

Outstanding Payments to Micro & Small Enterprises

Filing Type	As On	Amount Due to MSME	Current Liabilities	Ratio to Current Liabilities	Reasons for Delay

Investor Complaints & Serious Complaints About Vera Pharma Limited

Director Complain

Date	DIN	Cessation Date	Cessation Reason	Complaint

Serious Complaints

Date	Complaint	Other

Investor Complaints & Other Complaints

Date	Complaint Type	Complaint Sub Type	Particulars of Secutiries	Period	Complaint	Other Details

Prosecution Details of Vera Pharma Limited

S.No.	Defaulting Entities	Court Name	Prosecution Section	Date of Order	Status

FAQs- Vera Pharma Limited

What is VERA PHARMA LIMITED ?

VERA PHARMA LIMITED having CIN U24230TG1995PLC020644 is 10 years , 9 month old Public Indian Company incorporated with MCA on 01 Sep 2014. VERA PHARMA LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Hyderabad with an Authorized Share Capital of 85,000,000 and paid-up capital is 83,588,000.

What is the CIN of VERA PHARMA LIMITED?

CIN of VERA PHARMA LIMITED is U24230TG1995PLC020644.

Where is VERA PHARMA LIMITED located?

Address of VERA PHARMA LIMITED is 3-6-69, flat no. 409, venkatarama towers, basheerbagh,hyderabad,telangana,india-500029,.

Who are the directors of VERA PHARMA LIMITED ?

The company has 4 directors/key management personnel Ranganath Gorrepati,maganti Bijili Kumari,chandrashekar Rao,maganti Bijili Kumari,

What is the contact details of VERA PHARMA LIMITED ?

Email : verapharma@gmail.com
Address : H.No.8-3-833/79, Ground Floor, Kamalapuri Colony Phase III, Road No.2, Banjara Hills, HYDERABAD Telangana India 500073

What does VERA PHARMA LIMITED do?

VERA PHARMA LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing